NCT02869425View on ClinicalTrials.gov

To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

January 31, 2019

Conditions
Multiple SclerosisSperm
Interventions
DRUG

arbaclofen ER Tablets

arbaclofen ER tablets, 10 mg, 15 mg, or 20 mg

DRUG

Placebo for arbaclofen ER tablets

matching placebo tablets to arbaclofen ER tablets 10 mg, 15 mg or 20 mg

Trial Locations (2)

33169

Advance Medical Pain Management & Research Clinic, Miami

33604

Meridien Research, Tampa

Sponsors
All Listed Sponsors
collaborator

Osmotica Pharmaceutical US LLC

INDUSTRY

lead

RVL Pharmaceuticals, Inc.

INDUSTRY